Image: European Commission 2020
European Medicines Agency sees requests for help rise by a fifth but licence applications decrease
The European Medicines Agency saw a 20 per cent increase in requests for scientific advice from medicines developers in the first half of 2021 compared with the previous year, driven by the Covid-19 pandemic.
The regulator also reported that over the same period, the number of applications for drug licences dropped compared with 2020.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.